FDA Approves MYCOPHENOLIC ACID — Novugen Pharma (USA) LLC.
Novugen Pharma (USA) LLC has secured FDA approval for its Abbreviated New Drug Application #ANDA216637, generic MYCOPHENOLIC ACID (MYCOPHENOLATE SODIUM). This oral approval positions Novugen to enter the competitive market for immunosuppressant therapies, likely capturing market share from branded players.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed